483 Fresenius Kabi USA May 2020

483 Fresenius Kabi USA May 2020

Michele Glendenning FDA, Brian Nicholson FDA$119.00 - Available Now

FDA investigators audited the Fresenius Kabi USA - Melrose Park, IL, United States facility and issued inspectional observations (via FDA 483) on 18 May 2020.

Product details

  • Category: Human Drugs
  • Inspection end: 18 May 2020
  • Location: Melrose Park, United States
  • FEI: 1450022
Add To Cart